ClearPoint Neuro (CLPT) Cash from Operations Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 122.43% |
| 10 | ClearPoint Neuro | 430.65 Mn | 395.05 Mn | 7.76 Mn | -29.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.08% |
| Dec 31, 2025 | -873.45% |
| Sep 30, 2025 | -158.55% |
| Jun 30, 2025 | 5.25% |
| Mar 31, 2025 | -60.73% |
| Dec 31, 2024 | -6.33% |
| Sep 30, 2024 | 33.24% |
| Jun 30, 2024 | 47.43% |
| Mar 31, 2024 | 32.39% |
| Dec 31, 2023 | 61.86% |
| Sep 30, 2023 | 53.37% |
| Jun 30, 2023 | -1.89% |
| Mar 31, 2023 | -33.05% |
| Dec 31, 2022 | 13.71% |
| Sep 30, 2022 | -16.87% |
| Jun 30, 2022 | -33.97% |
| Mar 31, 2022 | -100.33% |
| Dec 31, 2021 | -47.94% |
| Sep 30, 2021 | -141.11% |
| Jun 30, 2021 | -117.68% |